SCHEMBL20660565

SCHEMBL20660565

Cc1cc(-c2ccc3cc(F)ccc3n2)ccc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MAOB P27338 3/20 0.41
▸ MAOA P21397 1/20 0.41
▸ APP P05067 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ PKM P14618 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MAP4K4 O95819 2/20 0.39
▸ CYP1A1 P04798 1/20 0.39
▸ AR P10275 2/20 0.39
▸ CTSD P07339 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20660400 0.90 AR (0.48) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL13399634 0.86 NPC1 (0.46) BACE1ALDH1A1MAOBMAOAESR1
SCHEMBL20660350 0.85 BACE1 (0.53) BACE1ALDH1A1CYP3A4MAOBMAOA
SCHEMBL17733598 0.85 KDM4E (0.53) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL20660363 0.85 BACE1 (0.53) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL20660654 0.84 BACE1 (0.51) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL20660538 0.82 ALDH1A1 (0.46) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL20660522 0.82 BACE1 (0.54) BACE1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL20660920 0.81 BACE1 (0.49) BACE1ALDH1A1MAOBMAOAESR1
SCHEMBL20660721 0.80 BACE1 (0.54) BACE1ALDH1A1TSHRMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. 2022-10-27 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS AHR, MCL1, ARNT BACE1 2063/4885ALDH1A1 172/4885CYP3A4 2631/4885
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS AHR, ARNT, RXRB BACE1 958/4885ALDH1A1 879/4885CYP3A4 280/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB BACE1 958/4885ALDH1A1 879/4885CYP3A4 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback